Proteome Sciences (LON:PRM) Hits New 12-Month Low – Time to Sell?

Proteome Sciences plc (LON:PRMGet Free Report)’s share price hit a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 2.25 ($0.03) and last traded at GBX 3.04 ($0.04), with a volume of 100307 shares trading hands. The stock had previously closed at GBX 2.70 ($0.04).

Proteome Sciences Price Performance

The firm has a market cap of £7.97 million, a price-to-earnings ratio of -270.00 and a beta of 0.07. The stock has a 50 day moving average of GBX 2.93 and a 200 day moving average of GBX 3.35.

Proteome Sciences Company Profile

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Read More

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.